scholarly article | Q13442814 |
P819 | ADS bibcode | 2012PLoSO...734850T |
P356 | DOI | 10.1371/JOURNAL.PONE.0034850 |
P932 | PMC publication ID | 3319602 |
P698 | PubMed publication ID | 22496870 |
P5875 | ResearchGate publication ID | 223978131 |
P50 | author | Steven A Belinsky | Q96685352 |
P2093 | author name string | Nancy Joste | |
Mathewos Tessema | |||
Yushi Liu | |||
Marcie J Grimes | |||
Shuguang Leng | |||
Cynthia L Thomas | |||
Christin M Yingling | |||
P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
TOX defines a conserved subfamily of HMG-box proteins | Q21093380 | ||
The DNA sequence and comparative analysis of human chromosome 20 | Q21735926 | ||
Evidence for involvement of HMGB1 protein in human DNA mismatch repair | Q24316068 | ||
TOX3 is a neuronal survival factor that induces transcription depending on the presence of CITED1 or phosphorylated CREB in the transcriptionally active complex | Q24318759 | ||
Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer | Q24321845 | ||
Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer. | Q24538785 | ||
CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
HMG1 and 2, and related 'architectural' DNA-binding proteins | Q28204610 | ||
Cloning and characterization of granulosa cell high-mobility group (HMG)-box protein-1, a novel HMG-box transcriptional regulator strongly expressed in rat ovarian granulosa cells | Q28570183 | ||
TOX3 regulates calcium-dependent transcription in neurons | Q28571543 | ||
Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis | Q30654912 | ||
Prognostic significance of cytoplasmic SOX9 in invasive ductal carcinoma and metastatic breast cancer. | Q50643429 | ||
Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. | Q51720467 | ||
TOX4 and its binding partners recognize DNA adducts generated by platinum anticancer drugs | Q56918884 | ||
HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas | Q74184034 | ||
SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma | Q84755546 | ||
Aberrant epigenetic silencing is triggered by a transient reduction in gene expression | Q33417274 | ||
HMGI(Y) and HMGI-C dysregulation: a common occurrence in human tumors | Q33725819 | ||
Diversification pattern of the HMG and SOX family members during evolution. | Q33858343 | ||
Minor groove-binding architectural proteins: structure, function, and DNA recognition. | Q34066853 | ||
TOX: an HMG box protein implicated in the regulation of thymocyte selection | Q34114649 | ||
Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis | Q34134446 | ||
Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins | Q34377284 | ||
DNA methylation and gene silencing in cancer: which is the guilty party? | Q34770507 | ||
Priming the nucleosome: a role for HMGB proteins? | Q35075720 | ||
SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15. | Q35840419 | ||
Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling | Q36571511 | ||
Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays | Q36614678 | ||
HMGB proteins: interactions with DNA and chromatin | Q37685443 | ||
SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell | Q39574549 | ||
Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model | Q39609163 | ||
Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. | Q40002585 | ||
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors | Q40213076 | ||
High-mobility group A1a protein regulates Ras/ERK signaling in MCF-7 human breast cancer cells | Q40596791 | ||
Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5' CpG island in human tumors | Q40927952 | ||
Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification | Q40951949 | ||
Chromosomal translocations in benign tumors: the HMGI proteins | Q41718116 | ||
Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma | Q43814414 | ||
Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. | Q44542352 | ||
Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3. | Q46571741 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | breast cancer | Q128581 |
P304 | page(s) | e34850 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Differential epigenetic regulation of TOX subfamily high mobility group box genes in lung and breast cancers | |
P478 | volume | 7 |
Q47719159 | ANK1 Methylation regulates expression of MicroRNA-486-5p and discriminates lung tumors by histology and smoking status |
Q47816021 | Common Subcluster Mining in Microarray Data for Molecular Biomarker Discovery. |
Q52608478 | Data mining of pediatric medulloblastoma microarray expression reveals a novel potential subdivision of the Group 4 molecular subgroup. |
Q58109380 | Deconstruction of DNA Methylation Patterns During Myogenesis Reveals Specific Epigenetic Events in the Establishment of the Skeletal Muscle Lineage |
Q35880987 | Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer |
Q34044005 | GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer |
Q37561150 | Gene-education interactions identify novel blood pressure loci in the Framingham Heart Study |
Q55035135 | Genome-wide analysis of DNA methylation in bronchial washings. |
Q33947935 | Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers |
Q64106252 | Genomic signature of parity in the breast of premenopausal women |
Q89919394 | High-mobility group box (TOX) antibody a useful tool for the identification of B and T cell subpopulations |
Q47143254 | Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis |
Q53427862 | Integrated DNA methylation analysis identifies topographical and tumoral biomarkers in pilocytic astrocytomas. |
Q35620383 | Integrative Analysis of Normal Long Intergenic Non-Coding RNAs in Prostate Cancer |
Q90612765 | Recurrent non-coding U1-snRNA mutations drive cryptic splicing in Shh medulloblastoma |
Q47704064 | TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic Leukemia |
Q35219716 | TOX acts an oncological role in mycosis fungoides |
Q26765220 | TOX gene: a novel target for human cancer gene therapy |
Q28854590 | TOX2 regulates human natural killer cell development by controlling T-BET expression |
Q90087593 | TOX3 is a favorable prognostic indicator and potential immunomodulatory factor in lung adenocarcinoma |
Q36640318 | TOX3 protein expression is correlated with pathological characteristics in breast cancer |
Q26778082 | The Role of TOX in the Development of Innate Lymphoid Cells |
Q90100218 | Tox4 modulates cell fate reprogramming |
Q31159752 | pETM: a penalized Exponential Tilt Model for analysis of correlated high-dimensional DNA methylation data |
Search more.